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Abstract. Due to the relatively high cost and inconvenience of upper endoscopic biopsy and the rising incidence
of esophageal adenocarcinoma, there is currently a need for an improved method for screening for Barrett’s
esophagus. Ideally, such a test would be applied in the primary care setting and patients referred to endoscopy
if the result is suspicious for Barrett’s. Tethered capsule endomicroscopy (TCE) is a recently developed
technology that rapidly acquires microscopic images of the entire esophagus in unsedated subjects. Here,
we present our first experience with clinical translation and feasibility of TCE in a primary care practice. The
acceptance of the TCE device by the primary care clinical staff and patients shows the potential of this device
to be useful as a screening tool for a broader population. © 2016 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10
.1117/1.JBO.21.10.104001]
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1 Introduction
Barrett’s esophagus (BE) is a condition associated with
male sex, older age (>50), Caucasian race, body mass index
(BMI) over 30, and chronic gastroesophageal reflux disease
(GERD).1 In BE, the normal squamous epithelium of the distal
esophagus is replaced by columnar metaplastic epithelium.2
Specialized intestinal metaplasia is the most common type
of metaplastic columnar epithelium and, though controversial,
is thought to be most associated with disease progression.3 BE
can develop low- and high-grade dysplasia, leading to esopha-
geal adenocarcinoma, a cancer with a poor overall 5-year
survival of 15% to 20%, which is growing in incidence.4,5 The
risk of developing esophageal adenocarcinoma is ∼0.12% to
0.33%/year for a patient with BE.6,7 Treatment of high-
grade dysplasia and superficial adenocarcinoma is possible and
curative at an early stage.8 As a result, some patients with BE
risk factors are screened for BE by performing an upper endos-
copy or esophagogastroduodenoscopy (EGD) with biopsies.
Patients found to have histopathologic evidence of specialized
intestinal metaplasia subsequently undergo regular endoscopic
surveillance.
Upper endoscopy is a time-consuming and costly examina-
tion, especially in most Western countries where conscious
sedation is a procedural requirement.9 In countries where the
endoscopic screening is performed without sedation, this exami-
nation is not well tolerated.10 For these reasons, many people with
BE risk factors are still not screened. Considering that most
(>90%) presenting with advanced esophageal adenocarcinoma
were never screened for nor therefore diagnosed with BE,11
there is a clear need for an improved screening tool. Such
a test would have the following features: well-tolerated by
patients, accurate for the detection of BE, and inexpensive.
Ideally, it would also be administered in the primary care physi-
cian (PCP) office, the central point of regular patient contact in
most health care systems.
We have previously introduced a method for minimally inva-
sive imaging of the human digestive system, termed tethered
capsule endomicroscopy (TCE),12,13 that involves swallowing
an engineered pill that collects cross-sectional microscopic
images of the entire esophagus as it traverses the luminal
organ. The capsule implements a second-generation form of
optical coherence tomography (OCT)14,15 named optical fre-
quency domain imaging16 or swept source OCT,17–19 capable
of collecting microscopic (10-μm axial resolution) cross-
sectional images of the esophagus.20–25 The device comprises
an 11 mm (diameter) ×24.8 mm (length) capsule connected to
a flexible, 0.96-mm-diameter sheath, which serves as a tether
(Fig. 1). The sheath encloses a driveshaft and an optical fiber;
the fiber transmits light to and receives light from the miniature
optics inside the capsule.
The feasibility of TCE for imaging BE has been previously
published.12,13 Here, we present our experience with the techni-
cal development and clinical translation of this device to the
primary care setting for BE screening.
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2 Methods
2.1 Tethered Capsule Endomicroscopy Design
Requirements
The design of the TCE device was derived through an iterative
process based on clinical, engineering, and regulatory require-
ments (Fig. 2). From a clinical use perspective, the imaging
device should be minimally invasive, allowing a well-tolerated
and short procedure requiring no sedation or special patient
preparation. Its resolution should comprehensively, and without
sampling error, enable microscopic visualization of structural
changes at the level required for diagnosing the conditions of
interest. Its diagnostic sensitivity should be high so as not to
miss BE cases, yet also with moderate-high specificity to
avoid unnecessary follow up EGDs. Its cost should be low
without the specialized requirements of endoscopy suites or
physicians to administer the device. Many of the engineering
requirements for the device were also dictated by the nature
of the digestive system (e.g., resistance to gastric acid and
capability to be effectively disinfected) and were common with
the design of the standard gastrointestinal (GI) endoscopes.
In addition to obtaining the highest safety profile, a large effort
was put into improving the ease of manufacturing the device.
2.2 Tethered Capsule Endomicroscopy Device
Figure 1 shows a photograph of the TCE device that was used in
the primary care office. The capsule has an 11 mm outer diam-
eter and a weight of 6 g to support natural peristalsis via gravity
and improve esophageal transit. A custom multilayered sheath
(microlumen) ensured flexibility while maintaining its shape,
pullability, and resistance to kinking. The connection between
the capsule and the sheath was covered with a flexible, tapered
strain relief to improve reusability of the device, and maintain
the integrity of the capsule-tether connection. A total of four
catheters were manufactured for use in the PCP study; one was
reused for 11 different examinations.
2.3 Tethered Capsule Endomicroscopy Pilot Study
in the Primary Care Physician’s Office
The PCP pilot study was focused on testing the safety and fea-
sibility of TCE in primary care practice (IRB P002014-001519).
The study was approved in July 2014 for imaging 20 adult
patients at the Internal Medicine Associates primary care clinic
at Massachusetts General Hospital (MGH) [Fig. 3(a)]. Subjects
scheduled for nonurgent visits to the clinic were eligible for this
study. The inclusion criteria were an age over 18 and informed
consent to the study. The exclusion criteria were history of intes-
tinal strictures, current symptoms of fever, nausea, dysphagia or
sore throat, and pregnancy.
The PCP study approval was followed by a meeting of all
investigators and personnel where the study design was
reviewed and each participant was assigned a role in the study.
The technical staff responsible for the conduct of the study intro-
duced the device to the staff at the clinic, including the nurses
and medical assistants. The PCP (L.H.S.) prescreened subjects
based on the date of their scheduled appointment and their
potential interest and eligibility for the study. After confirmation
that all inclusion and exclusion criteria were met, subjects
received a consent form and description of the study by mail
and then were contacted by the research nurse over the
phone. Subjects were asked to fast for 4 h prior to the scheduled
appointment. On the day of the procedure, subjects met with the
research nurse and a prequestionnaire was filled out to ensure
that subjects did not have any exclusion criteria before meeting
with the PCP. Fasting status was confirmed, and written consent
was obtained by PCP (L.H.S.).
2.4 Tethered Capsule Endomicroscopy Imaging
Procedure
The TCE procedure was approved to be performed before or
after the scheduled PCP visit depending on the arrival of the
Fig. 1 TCE device comprising a capsule attached to the distal end of
a flexible tether and terminated with an optical connector at the
proximal end.
Fig. 2 Schematic representation of the device design process.
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patient and the availability of the consenting physician. After the
subject was given informed consent, clinical characteristics such
as age, sex, BMI, current medication regimen, and GI history
were recorded. Prior to the procedure, the subjects were invited
to watch a short presentation that included a recording of prior
TCE procedures and a description of the study.
Prior to study initialization, the research nurse (C.N.G.) was
trained to perform all TCE procedures. Operator training com-
prised: reviewing recordings of TCE procedures captured during
previous TCE studies performed by an experienced research
nurse and a demonstration of the optimal speed for catheter
navigation in the esophagus. In the next training step, the nurse
performed two TCE procedures in an ongoing TCE study (IRB
P0011-2619): the first one under supervision of the endoscopist
with previous TCE experience and the second one without
supervision. A simplified diagram of the procedure [Fig. 3(b)]
was available to the nurse at all times. The nurse was accom-
panied by an experienced TCE imaging system operator
(M.J.G.) and an additional study staff responsible for filling
out case report forms (A.T.).
As shown in Fig. 3(b), the TCE clinical procedure was di-
vided into three phases. The first swallowing phase was similar
to the administration of video capsule endoscopy devices:
the nonsedated subject swallowed the capsule voluntarily while
sipping water. The subjects were given a maximum of five
swallowing attempts. They were also encouraged to sip water
to help the swallowing process. Subjects were offered the option
of coating the capsule with Pill Glide™, a flavored over-the-
counter lubricant spray that previously was successfully used
for enhancing subjects’ ability to swallow.
After the capsule was swallowed, the imaging phase began
and the TCE operator navigated the device through the upper GI
tract similarly to a transnasal endoscope,21 except that the cap-
sule’s transit was governed by gravity and peristalsis until the
capsule reached the stomach. Another difference was the way
the device passed anatomical sphincters, such as the lower
esophageal sphincter or upper esophageal sphincter during with-
drawal. The natural response of these sphincters was to constrict
and prevent the capsule from moving proximally from one
portion of the GI tract to the other. During the pullback of
the capsule using the tether, the sphincters were relaxed with
a dry swallow or small sips of water taken by the subject.
The study was approved for imaging the esophagus and proxi-
mal stomach up to four times. Throughout the capsule’s transit,
the research nurse read the capsule’s position from the incisors
using 5-cm marks on the tether. These readings were recorded
in case report forms with corresponding TCE image frame
numbers.
In order to collect OCT images of the highest quality, it was
critical to ensure good contact between the lumen and the cap-
sule wall during transit.22 If, during the imaging phase, loss
of contact due to peristaltic relaxation was observed in the
OCT image displayed in real-time, the catheter operator was
instructed to stop the capsule by holding the tether at the inci-
sors. The subject was then asked to dry swallow or sip water to
reengage peristalsis. The dynamic response of the esophagus
could be seen in the OCT data in real-time with first the expan-
sion of the lumen, then passage of the bolus of water, and finally
a constriction of the lumen around the capsule, at which point
the capsule’s motion was reinitiated.
The last phase of the procedure involved the removal of the
capsule through the upper esophageal sphincter and the mouth.
Even though sipping water efficiently relaxed the upper esopha-
geal sphincter, it was rather cumbersome for the patient and the
operator to pull the capsule out while swallowing liquid. The
recommended method was to use breathing to open the sphinc-
ter. Once the capsule was out of the mouth, the total time of
the procedure was recorded.
After the TCE examination, subjects were asked a set of
questions:
1. How anxious did you feel before swallowing the pill?
(1. not anxious to 4. very anxious)
2. How much discomfort did you have during the pro-
cedure? (1. none to 4. a lot)
Fig. 3 (a) Photograph of the OCT imaging console in the primary care examination room and
(b) schematic representation of the TCE procedure.
Journal of Biomedical Optics 104001-3 October 2016 • Vol. 21(10)
Gora et al.: Tethered capsule endomicroscopy: from bench to bedside at a primary care practice
Downloaded From: http://biomedicaloptics.spiedigitallibrary.org/ on 02/24/2017 Terms of Use: http://spiedigitallibrary.org/ss/termsofuse.aspx
3. What was the hardest part of the procedure for you?
4. Would you recommend the TCE procedure to others?
(1. definitely yes to 4. definitely no).
According to the sterilization method in place at the MGHGI
unit for endoscopes and manometry probes, the TCE device
underwent a high level disinfection before each use at the
MGH Sterile Processing Department by submersion in Cidex
OPA for 12 min. After use, the TCE device was disinfected,
sealed, and stored.
3 Results
3.1 Subject Enrollment in the Primary Care
Physician Setting
Twenty subjects were enrolled from September 2014 to March
2015 [Fig. 4(a)]. Figure 4(b) represents the enrollment process
for the study. Approximately 240 subjects were scheduled for
nonurgent visits during enrollment hours, 217 were prescreened
by the PCP, and 195 received information about the study by
mail. Thirty-eight out of 69 subjects reached by phone were inter-
ested in participating in the study; 20 subjects were enrolled based
on personnel and equipment availability. On the day of each
study, the TCE system was transferred to the PCP unit and set
up for the procedure in a designated outpatient examination room.
3.2 Primary Care Physician Study Population and
Study Outcomes
Out of 20 enrolled subjects 11 were men, the average BMI was
27 4.7 kg∕m2, and the average age was 52 13 years old
(Table 1). After reviewing the medical files, eight patients
(40%) were found to have a history of GERD and three had
already undergone an EGD for conditions other than BE (15%).
Subjects were, on average, a little anxious before the pro-
cedure with preswallowing anxiety of 2.1 0.8. The average
number of swallow attempts was 2 1.5. Three patients
(15%) were unable to swallow the capsule. Among the subjects
who successfully swallowed the capsule, 16 (94%) declared
they would definitely recommend the procedure and 1 (6%)
said they would probably recommend it. The total TCE pro-
cedure time was 4.8 2.6 min with an average of 3.7 0.7
passes in the esophagus before removal. Subjects experienced
only a little discomfort (1.9 0.9) during the procedures.
During the study, the research nurse introduced a new
method for capsule removal based on a double breath technique,
where the capsule was pulled out during the subject’s second
deep breath. With this method, the percentage of subjects who
identified capsule removal as the most difficult part of the
procedure was reduced from 42% found in a prior study12,13
to 29% in the current study.
Fig. 4 (a) Patient enrollment process and (b) timeline of the PCP study. Blue circles represent successful
PCP imaging procedures. Stars represent investigator meetings. Triangles correspond to procedures in
which the capsule was not swallowed and diamonds correspond to training procedures.
Table 1 Demographic characteristics and procedural tolerance in the
study population.
Characteristics
Age (year) (mean SD) 52 13
Men (%) 11(55%)
BMI (kg∕m2) (mean SD) 27 4.7
GERD (%) 8 (40%)
Race or ethnic group (%)
Black or African American 2 (10%)
Asian 1 (5%)
Caucasian 17 (85%)
Procedure
Swallowing success (%) 17 (85%)
Number of swallow attempts (mean SD) 2 1.5
Total capsule time (min) (mean SD) 4.8 2.6
Preswallowing anxiety (mean SD)
[(1) Not at all anxious. (2) A little anxious.
(3) Moderately anxious. (4) Very anxious.
(5) Extremely anxious.]
2.1 0.8
Discomfort during procedure (mean SD)
[(1) None. (2) A little. (3) Some. (4) A lot]
1.9 0.9
Recommendation of the procedure (mean SD)
[(1) I would definitely recommend it. (2) I would
probably recommend it. (3) I would probably not
recommend it. (4) I would definitely not
recommend it.]
1.1 0.2
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3.3 Tethered Capsule Endomicroscopy Image
Analysis
The start and end positions of the capsule in the esophagus were
recorded for all imaging passes based on marks on the tether. For
56 out of 61 passes, the capsule positions versus frame numbers
were recorded every 5 cm. Based on these recordings, the aver-
age length of the esophagus imaged during all studies was 15
6 cm with the average starting point in the proximal esophagus
at 30 6 cm. The average velocity of ascending imaging, deter-
mined by manual pullback of the tether, was 33.7 mm∕s with a
standard deviation of 16.8 mm∕s. This variability in the length
of the imaged esophagus was observed even though the same
research nurse performed all the procedures. The optimal pull-
back velocity is a tradeoff between minimal frame separation
(equal to 30 μm spot size), short procedure time, and ease of
pulling the capsule. Based on the feedback from the catheter
operator, it was difficult to perform a very slow pullback. In
the interest of maintaining a short procedure duration, the opti-
mal pullback speed was set to be 20 mm∕s corresponding to
a 100-μm longitudinal separation between cross-sectional TCE
frames. In a majority of cases, the capsule was pulled out faster
than the optimal pullback speed, providing an average frame
separation for the collected 64,489 frames in 61 imaging
runs of ∼140 μm.
The image signal-to-noise ratio (iSNR) was calculated for
each frame by using the region in the image between the reflec-
tance from the capsule inner and outer surfaces as the noise
floor. The average iSNR of all datasets was 24.46 3.44 dB,
which indicates an adequate and reliable iSNR throughout
every imaging run. Even the lowest iSNR from all 17 patients
(17.23 dB) provided a usable dataset, as determined by expert
reviewers (M.G. and G.T.). As a result, image quality was con-
sidered to be adequate for all subjects in this study.
For all subjects who swallowed the capsule, the device
passed the lower esophageal sphincter and entered the stomach,
allowing imaging of the gastroesophageal junction (GEJ), where
BE can develop. A side-by-side comparison of these anatomical
landmarks in two selected subjects is shown in Fig. 5. Normal
features of the esophageal wall, such as a layered mucosa and
a good tissue penetration depth, are displayed in Figs. 5(a) and
5(d). The proximal stomach or cardia [Figs. 5(c) and 5(f)],
on the other hand, has a very poor penetration into the tissue
and a typical “pit pattern” (blue arrowheads) that is visible on
the surface of the tissue. The transition between these two tissues
types at the GEJ is shown with a presumably normal appearance
in a 36-year-old female [Fig. 5(b)] that can be compared to
another transition with somewhat atypical glandular architecture
in a 66-year-old female subject [Fig. 5(e)]. Similarly, irregularly
shaped glands were also seen in the gastric cardia [Fig. 5(f)] of
this subject. All three tissue types (squamous, GEJ, and cardia)
were present in 57 out of the total of 61 passes. In three passes,
only images of the esophagus were captured and in one pass,
only images of the stomach were captured.
Visualization of more than 50% of the full circumference per
frame was achieved in 92.3% of all 57,679 frames acquired in
the esophagus and the GEJ. In every subject who swallowed the
capsule, we obtained at least one imaging run where the entire
circumference of the esophagus and the GEJ were clearly visu-
alized in more than 85% of the frames. The last ascending im-
aging run typically had the best tissue visualization, where the
full circumference of the esophagus and GEJ were clearly seen
in 97 ± 5% of the frames, and the first descending run had
the lowest tissue visualization, where the full circumference
Fig. 5 Examples of TCE cross-sectional frames selected from three-dimensional data obtained in (a, b,
c) a 36-year-old female—subject A and (d, e, f) a 66-year-old female—subject B. These images depict
typical features and landmarks found in the OCT images of this study. The top row shows characteristic
layered architecture of the esophageal wall with submucosal glands (blue arrowheads) in both subjects.
In the example on the right (d), the submucosal gland empties into a duct that emanates at the lumen
(green asterisk). The middle row shows a side-by-side comparison of the GEJ, demonstrating the tran-
sition of tissue from the squamous mucosa to the stomach’s cardia, depicting a common appearance in
subject A (b) and an uncommon appearance characterized by the presence of glandular architecture
(blue arrowhead) in subject B (d). The bottom row shows a typical pit pattern (blue arrowheads) on
the surface of the gastric cardia in both subjects. In addition, subsurface glandular structures (green
asterisks) can be seen below the surface of the cardia in subject B (f).
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of the esophagus and GEJ were clearly visible in 86 9% of
the frames.
4 Discussion
We have undertaken many steps to move this advanced capsule-
based microscopic imaging technology, intended for screening,
from the bench to the bedside to the primary care clinic. The
very first TCE procedures were performed in an endoscopy
suite in the MGH endoscopy unit by gastroenterologists with
expertise in endoscopy.12 Following success of the first cases,
the TCE procedures were moved to a regular examination
room in the GI Associates Practice at MGH, where patients
were seated on an examination bed.13 Based on demonstrated
safety and ease of use, a trained research nurse from the GI unit
was approved as the capsule operator. In this study, the technol-
ogy was transferred to the primary care practice environment
and the procedure was performed in a broader range of patients.
This first study of TCE in the primary care population shows
that this procedure is feasible in this setting, with an 85% swal-
lowing rate, a comprehensive examination time of less than
5 min, and the acquisition of good quality images in all cases.
The procedure was successfully performed in the primary care
setting that required adaptation to patients presenting without
specific procedure preparation and in an exam room setting
that was not designed necessarily for the performance of office
procedures. Flexibility of positioning of equipment was required
and was successful, e.g., in the case of a subject who used a
wheelchair. The age range (25 to 66 years) here was also larger
than that of prior TCE studies.12,13 Subject acceptability of
the technique was good as demonstrated by an expression of
only minor discomfort and the fact that all participants would
recommend this procedure to others.
In addition, the TCE technology was well received by physi-
cians and staff in the primary care practice. The examination was
short and it was therefore possible to image patients during their
time in the PCP unit without disturbing the workflow. Feedback
from physicians and staff were encouraging. One of the high-
lighted advantages of TCE was the fact that the procedure
did not require any special preparation for patients other than
fasting for 4 h. We also identified inputs to further improve
the implementation of TCE in the PCP setting, including a much
smaller imaging system footprint and single-user operation.
Regarding the demographics of subjects imaged in this study,
it was a diverse population with a substantial rate of GERD
(40%). The majority of this cohort were white, all 11 men
(100%) were over 35 years, 5 women (55%) were over 50
years of age, and 12 subjects (60%) were overweight, which
are all risk factors for BE.1 Only one patient had no risk factors
for BE. Thus, this cohort represented a reasonable screening
population for BE.
It is important to properly plan the timeline of the clinical
study when translating a new technology. As presented in
this paper, 20 subjects were enrolled in 16 weeks of active
enrollment after contacting 102 patients by phone. Even though
more subjects were interested in participating in the study, TCE
device manufacturing limited the availability of the technology
for enrollment. The effort in optimization of the device resulted
in a technology well adapted to clinical use; however, in-house
manufacturing of the device required highly trained personnel.
It has to be mentioned that the transfer of a new technology to
a designated environment is most commonly done after com-
mercialization of the technology. In this study, this step was
achieved with a research device. We learned that development
of new solutions for decreasing the complexity of the device is
necessary. Efforts were made toward solving this problem by
outsourcing the manufacturing of certain subcomponent/assem-
blies. However, outsourcing the entire device at a reasonable
cost was not feasible for our research and would limit our
capabilities to further optimize the device.
The study has some limitations. Even though the goal of this
study was not to measure the diagnostic accuracy of TCE for
BE, but to assess its feasibility and acceptability, a limitation
was the lack of comparison with endoscopic examination and
biopsy. Implementation of a validated anxiety scale would have
also been useful to standardize the results and compare this new
technique to others already implemented in the clinic.26–29
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